MedTrace Logo

Anti Vitamin K Therapeutic Education

NCT01587053 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2020-12-02

No results posted yet for this study

Summary

The purpose of this study is to measure the INR (International Normalized Ratio) time percentage in the target zone (TTR: time in therapeutic range) of children benefiting from the AVK therapeutic education program.

Conditions

  • Cardio-vascular Diseases

Interventions

OTHER

therapeutic education program

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Pascal AMEDRO, MD, PhD · Pediatric and Congenital Cardiology and Pulmonology Department, Arnaud De Villeneuve University Hospital

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01587053 on ClinicalTrials.gov